Presentation
The Paris Transplant Group (PTG) is developing a personalized approach for transplant medicine that integrates multidimensional information derived from standard of care (clinical and biological data, histology and immunology) together with novel information coming from cutting edge technologies in immunology, molecular biology, genetics and biomarkers.
The team includes several departments in kidney, heart, lung and liver transplantation, which are known as reference centres.
Kidney transplant
Our consortium includes leading national kidney transplant centers totalling more than 530 transplants each year
Heart transplant
The centers dedicated to heart transplant represent more than 80% of the overall national heart transplant activity (150 transplants each year).
Lung transplant
Our consortium includes leading transplant centers with more than 75 transplants each year.
Liver transplant
Our consortium of liver transplant centers, collaborating seamlessly, conducts over 400 liver transplant procedures annually.
PTG builts the largest comprehensive multi-organ cohort worldwide.
More than
Latest News of the Research Team
Connect with us on Twitter
New technology fuels sustainable post transplantation care ESOT Congress 2025 !
Understanding supporting and improving humain décision-making in transplantation y @LoupyAlex @DivardG @ParisTxGroup @VGoutaudier @ESOTtransplant @ag_biomedecine
Association of cell free DNA with MVI in Kidney allografts by @MartaSablik @ParisTxGroup @ESOTtransplant #Esot25
📢 Join the webinar series on the new @TheLancet Clinical Series on Solid Organ Transplantation!
🌍Experts discuss innovations in:
🔬 July 7 – Organ assessment & generation
🧬 July 17 – Monitoring & precision immunosuppression
⚖️ July 25 – Policy & equity
📢 Just out in @NatureComms & presented @ESOTtransplant !
Our study "Impact of HLA evolutionary divergence and molecular mismatches on AMR of kidney allografts" is now published.
🔗
🙌to @zpdemir2
Carmen Lefaucheur @AlexandreLoupy
Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated...
Nature Communications - Kidney transplants are at risk of graft failure due to immune system rejection. Here, the ...
www.nature.com
🔬 Just published in @TheLancet: a new Clinical Series on Solid Organ Transplantation, co-authored by experts around the globe.
📖 Read the full Series:
Thread below 👇
#ESOT2025 @AlexandreLoupy @MartaSablik @PeterPReese1 @KiranKhush1
Solid Organ Transplantation
Solid organ transplantation brings tremendous benefits to many patients with end-stage organ disease. However, challenges ...
www.thelancet.com
I see progress in figuring out how to guide immunosuppression toward individual patients' needs Amazing work here by Alex Loupy’s group illuminating how cell-free DNA reveals allograft inflammation, but a clinician needs to interpret in the clinical context. @AlexandreLoupy
Happy to share with the community
@ParisTxGroup we have 27 oral communications at #ESOT2025! covering all aspects of transplant research
contact us for exchanging and partnerships !!! #PITOR
Beyond standard of care monitoring for patients who are post-transplant, urinary chemokine CXCL9 demonstrated limited clinical utility, while CXCL10 provided no additional value. http://kidney.pub/JASN0742 #ASNJASN
Direct from Choose Europe 🇪🇺for Science: A Bold Step from Paris 🇫🇷 !
Transplant researchers: if you’re ready to innovate, 🇫🇷 might be your next destination🛬.
@ParisTxGroup is ready 🚀🤖🦾#PITOR #FranceForScience DM me if interested
